Fernand Labrie

Publications

Page 9 of 26, showing 50 records out of 1263 total, starting on record 401, ending on 450

Publication Category Year
106. Vaillancourt, L., Têtu, B., Fradet, Y., Dupont, A., Gomez, J., Cusan, L., Suburu, R.E., Diamond, P., Candas, B., Labrie, F. (1996). Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma: a randomized study. Am. J. Surg. Pathol., 20: 86-93. All publications 1996
107. van der Kwast, T.H., Tetu, B., Fradet, Y., Dupont, A., Gomez, J., Cusan, L., Diamond, P., Labrie, F. (1996) Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy. Prostate, 28: 227-231. All publications 1996
456. Auger, S., Mérand, Y., Pelletier, J.D., Poirier, D., Labrie, F. (1995) Synthesis and biological activities of thioether derivatives related to the antiestrogens tamoxifen and ICI 164384. J. Steroid Biochem. Mol. Biol., 52: 547-565. All publications 1995
108. Bélanger, A., Van Halbeek, H., Graves, H.C.B., Grandbois, K., Stamey, T.A., Lihua, H., Poppe, I., Labrie, F. (1995) Molecular mass and carbohydrate structure of prostate specific antigen: studies for establishment of an international PSA standard. Prostate, 27: 187-197. All publications 1995
457. Blais, Y., Sugimoto, K., Carrière, M.C., Haagensen, D.E., Labrie, F., Simard, J. (1995) Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1alpha on apolipoprotein D and GCDFP-15 expression in human breast cancer cells. Int. J. Cancer, 62: 732-737. All publications 1995
109. Chen, C., Puy, L.A., Simard, J., Li, X., Singh, S.M., Labrie, F. (1995) Local and systemic reduction by topical Finasteride or Flutamide on hamster flank organ size and enzyme activity. J. Invest. Dermatol., 105: 678-682. All publications 1995
632. Dalla Valle, L., Couet, J., Labrie, Y., Simard, J., Belvedere, P., Simontacchi, C., Labrie, F., Colombo, L. (1995) Occurrence of cytochrome 450c17 mRNA and dehydroepiandrosterone biosynthesis in the rat gastrointestinal tract. Mol. Cell. Endocrinol., 111: 83-92. All publications 1995
900. Doualla-Bell, F., Bonneau, M.J., Labrie, F., Fortier, M.A. (1995) Differential effects of a steroidal antiestrogen, EM-139, on prostaglandin and cAMP production in the circular and longitudinal layers of bovine myometrium. Biol. Reprod., 52: 1358-1363. All publications 1995
3825. Doualla-Bell, F., Lye, S.J., Labrie, F., Fortier, M.A. (1995) Differential expression and regulation of connexin-43 and cell-cell coupling in myocytes from the circular and longitudinal layers of bovine myometrium. Endocrinology, 136: 5322-5328. All publications 1995
901. Durocher, F., Morissette, J., Labrie, Y., Labrie, F., Simard, J. (1995) Mapping of the HSD17B2 gene encoding type II 17beta-hydroxysteroid dehydrogenase close to D16S422 on chromosome 16q 24.1-q24.2. Genomics, 25: 724-726. All publications 1995
902. Ghosh, D., Pletnev, V.Z., Zhu, D.-W., Wawrzak, Z., Duax, W.L., Pangborn, W., Labrie, F., Lin, S.-X. (1995) Structure of human estrogenic 17beta-hydroxysteroid dehydrogenase at 2.20 a resolution. Structure, 3: 503-513. All publications 1995
3828. Ghosh, D., Wawrzak, Z., Pletnev, V., Erman, M., Duax, W.L., Pangborn, W., Zhu, D.W., Labrie, F., Lin, S.X. (1995) Molecular mechanism of inhibition of steroid dehydrogenases by licorice-derived steroid analogs in modulation of steroid receptor function. Ann. N. Y. Acad. Sci., 761: 341-343. All publications 1995
903. Guérin, S.L., Leclerc, S., Verreault, H., Labrie, F., Luu-The, V. (1995) Overlapping cis-acting elements located in the first intron of the gene for type I 3beta-hydroxysteroid dehydrogenase modulate its transcriptional activity. Mol. Endocrinol., 9: 1583-1597. All publications 1995
3830. Han, X., Rossdale, P.D., Ousey, J., Holdstock, N., Allen, W.R., Silver, M., Fowden, A.L., McGladdery, A., Labrie, F., Bélanger, A., Ensor, C.M., Tai, H.H., Challis, J.R.G. (1995) Localization of 15-hydroxy prostaglandin dehydrogenase (PGDH) and steroidogenic enzymes in the equine placenta. Equine Vet. J., 27: 334-339. All publications 1995
110. Labrie, F. (1995) Endocrine therapy of prostate cancer: optimal form and timing. J. Clin. Endocrinol. Metab., 80: 1066-1071. All publications 1995
634. Labrie, F., Bélanger, A., Simard, J., Luu-The, V., Labrie, C. (1995) DHEA and peripheral androgen and estrogen formation: intracrinology. Ann. N.Y. Acad. Sci., 774: 16-28. All publications 1995
111. Labrie, F., Bélanger, A., Simard, J., Luu-The, V., Labrie, C. (1995) Intracrinologie: autonomie et liberté des tissus périphériques. Ann. Endocrinol. (Paris), 56: 23-29. All publications 1995
112. Labrie, F., Crawford, D.; (1995) Anti-androgens in treatment of prostate cancer. Lancet, 346: 1030-1031. All publications 1995
113. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Candas, B. (1995) Combination of screening and preoperative endocrine therapy: the potential for an important decrease in prostate cancer mortality. J. Clin. Endocrinol. Metab., 80: 2002-2013. All publications 1995
114. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R., Lemay, M., Candas, B. (1995) Screening und Re-Screening des Prostatakarzinoms: Die Quebec-Studie, in Faul, P. et Altwein, J.E., eds: Screening des Prostatakarzinoms, Berlin, Springer-Verlag, pp 339-352. All publications 1995
115. Labrie, F., Cusan, L., Gomez, J.L., Diamond, P., Suburu, R., Lemay, M., Tetu, B., Fradet, Y., Candas, B. (1995) Downstaging by combination therapy with flutamide and an LHRH agonist before radical prostatectomy. Cancer Surv. 23: 149-156. All publications 1995
459. Labrie, F., Li, S., Labrie, C., Lévesque, C., Mérand, Y. (1995) Inhibitory effect of a steroidal antiestrogen (EM-170) on estrone-stimulated growth of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 33: 237-244. All publications 1995
908. Labrie, Y., Durocher, F., Lachance, Y., Turgeon, C., Simard, J., Labrie, C., Labrie, F. (1995) The human type II 17beta-hydroxysteroid dehydrogenase gene encodes two alternatively-spliced messenger RNA species. DNA Cell Biol., 14: 849-861. All publications 1995
460. Li, S., Lévesque, C., Geng, C.S., Yan, X., Labrie, F. (1995) Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat. Breast Cancer Res. Treat., 34: 147-159. All publications 1995
910. Li, X., Chen, C., Singh, S.M., Labrie, F. (1995) The enzyme and inhibitors of 4-ene-3-oxosteroid 5alpha-reductase. Steroids, 60: 430-441. All publications 1995
116. Li, X., Singh, S.M., Côté, J., Laplante, S., Veilleux, R., Labrie, F. (1995) Synthesis and in vitro evaluation of 4-substituted-N-(1,1-dimethylethyl)-3-oxo-4-androsten-17beta-carboxamides as 5alpha-reductase inhibitors and antiendrogens. J. Med. Chem., 38: 1456-1461. All publications 1995
117. Li, X., Singh, S.M., Labrie, F. (1995) Synthesis and in vitro activity of 17beta-(N-alkyl)formamido/ alkylamido-4-aza-/4-methyl-4-aza-3-oxo-5beta-androstan-3-ones as inhibitors of human 5alpha-reductase and antagonists on the androgen receptor. J. Med. Chem., 38: 1158-1173. All publications 1995
118. Li, X., Singh, S.M., Lourdusamy, M., Mérand, Y., Veilleux, R., Labrie, F. (1995) Synthesis and in vitro antiandrogenic activity of 17beta-hydroxy-17beta-(w-hydroxy/haloalkyn-1'-yl)-4-methyl-4-aza-3-oxo-5beta-androstan-(1-ene)-3-ones. Bioorg. Med. Chem. Lett., 5: 1061-1064. All publications 1995
3845. Lourdusamy, M., Labrie, F., Singh, S.M. (1995) Synthesis of Atamestane (SH 489): An aromatase inhibitor. Synth. Comm., 25: 3655-3662. All publications 1995
635. Luu-The, V., Dufort, I., Paquet, N., Reimnitz, G., Labrie, F. (1995) Structural characterization and expression of the human dehydroepiandrosterone sulfotransferase gene. DNA Cell Biol., 14: 511-518. All publications 1995
915. Luu-The, V., Zhang, Y., Poirier, D., Labrie, F. (1995) Characteristics of human types 1, 2, and 3 17beta-hydroxysteroid dehydrogenase activities: oxidation reduction and inhibition. J. Steroid Biochem. Mol. Biol., 55: 581-587. All publications 1995
916. Mébarki, F., Sanchez, R., Rhéaume, E., Laflamme, N., Simard, J., Forest, M.G., Bey-Omar, F., David, M., Labrie, F., Morel, Y. (1995) Nonsalt-losing male pseudohermaphroditism due to the novel homozygous N100S mutation in the type II 3beta-hydroxysteroid dehydrogenase (HSD3B2) gene. J. Clin. Endocrinol. Metab., 80: 2127-2134. All publications 1995
917. Morissette, J., Rhéaume, E., Leblanc, J.-F., Luu-The, V., Labrie, F., Simard, J. (1995) Genetic linkage mapping of HSD3B1 and HSD3B2 encoding human types I and II 3beta-hydroxysteroid dehydrogenase/delta5-delta4-isomerase close to D1S514 and the centromeric D1Z5 locus. Cytogenet Cell Genet, 69: 59-62. All publications 1995
119. Narod, S., Dupont, A., Cusan, L., Diamond, P., Gomez, J.L., Suburu, R., Labrie, F. (1995) The impact of family history on early detection of prostate cancer. Nature Medicine, 1: 99-101. All publications 1995
918. Pelletier, G., Luu-The, V., Labrie, F. (1995) Immunocytochemical localization of type I 17beta-hydroxysteroid dehydrogenase in the rat brain. Brain Res., 704: 233-239. All publications 1995
919. Rhéaume, E., Sanchez, R., Mébarki, F., Gagnon, E., Carel, J.C., Chaussain, J.L., Morel, Y., Labrie, F., Simard, J. (1995) Identification and characterization of the G15D mutation found in a male patient with 3beta-hydroxysteroid dehydrogenase (3beta-HSD) deficiency: alteration of the putative NAD-binding domaine of type II 3beta-HSD. Biochemistry, 34: 2893-2900. All publications 1995
3853. Seralini, G.E., Luu-The, V., Labrie, F. (1995) Cloning and expression of human tyrosine aminotransferase cDNA. Biochim. Biophys. Acta, 1260: 97-101. All publications 1995
461. Shattuck-Eidens, D., McClure, M., simard, J., Labrie, F., Narod, S.A., Couch, F.J., Hoskins, K., Weber, B., Castilla, L., Erdos, M.E.A. (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications of presymptomatic testing and screening. JAMA, 273: 535-541. All publications 1995
920. Simard, J., Rhéaume, E., Mébarki, F., Sanchez, R., New, M.I., Morel, Y., Labrie, F. (1995) Molecular basis of human 3beta-hydroxysteroid dehydrogenase deficiency. J. Steroid Biochem. Mol. Biol., 53: 127-138. All publications 1995
921. Simard, J., Sanchez, R., Durocher, F., Rhéaume, E., Turgeon, C., Labrie, Y., Luu-The, V., Mebarki, F., Morel, Y., de Launoit, Y., Labrie, F. (1995) Structure-function relationships and molecular genetics of the 3beta-hydroxysteroid dehydrogenase gene family. J. Steroid Biochem. Mol. Biol., 55: 489-505. All publications 1995
364. Sugimoto, Y., Lopez-Solache, I., Labrie, F., Luu-The, V. (1995) Cations inhibit specifically Type I 5alpha-reductase found in human skin. J. Invest. Dermatol., 104: 775-778. All publications 1995
120. Sun, S., Narod, S., Aprikian, A., Ghadirian, P., Labrie, F. (1995) Androgen receptor and familial prostate cancer. Nature Medicine, 1: 848-849. All publications 1995
3860. Tchernof, A., Després, J.P., Bélanger, A., Dupont, A., Prud'Homme, D., Moorjani, S., Lupien, P.J., Labrie, F. (1995) Reduced testosterone and adrenal C19 steroid levels in obese men. Metabolism, 44: 513-519. All publications 1995
3859. Tchernof, A., Després, J.P., Bélanger, A., Dupont, A., Prud'Homme, D., Moorjani, S., Lupien, P.J., Labrie, F. (1995) Relation of steroid hormones to glucose tolerance and plasma insulin levels in men. Importance of visceral adipose tissue. Diabetes Care, 18: 292-299. All publications 1995
462. Tonin, P.N., Moslehi, R., Green, R., Rosen, B., Cole, D., Boyd, N., Cutler, C., Margolese, R., Carter, R., McGillivray, B., Yves, E., Labrie, F., Gilchrist, D., Morgan, K., Simard, J., Narod, S.A. (1995) Linkage analysis of 26 Canadian breast and breast-ovarian cancer families. Hum. Genet, 95: 545-550. All publications 1995
3862. Vohl, M.C., Couture, P., Moorjani, S., Torres, A.L., Gagné, C., Després, J.P., Lupien, P.J., Labrie, F., Simard, J. (1995) Rapid restriction fragment analysis for screening four point mutations of the low-density lipoprotein receptor gene in French Canadians. Hum. Mutat, 6: 243-246. All publications 1995
924. Zhu, D.-W., Zhou, M., Mao, Y., Labrie, F., Lin, S.-X. (1995) Crystallization of human estrogenic 17beta-hydroxysteroid dehydrogenase under microgravity. J. Cryst. Growth, 156: 108-111. All publications 1995
121. Bélanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.L., Labrie, F. (1994) Changes in serum concentration of conjugated and unconjugated steroids in 40- to 80-year old men. J. Clin. Endocrinol. Metab., 79: 1086-1090. All publications 1994
926. Bernier, F., Leblanc, G., Labrie, F., Luu-The, V. (1994) Structure of human estrogen and aryl sulfotransferase gene: Two mRNA species issued from a single gene. J. Biol. Chem., 269: 28200-28205. All publications 1994
927. Bernier, F., Lopez, I., Labrie, F., Luu-The, V. (1994) Cloning and expression of cDNA encoding human placental estrogen sulfotransferase. Mol. Cell. Endocrinol., 99: R11-R15. All publications 1994
<< previous | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 next >>

Biography  |  Publications  |  Scientific Conferences  |  Selected Slide Presentations  |  Awards